Patient on Road to Recovery Thanks to Neuroscience Team, and Time

After collapsing from a heart attack in December 2017, 51-year-old Mary Cooper remained in status epilepticus, or a constant state of seizure activity for nearly two weeks. With continuous EEG monitoring, available in the region only at UC Medical Center’s neurocritical care unit, specialists at the UC Gardner Neuroscience Institute were able to get her seizure activity under control to begin the brain’s healing process. 

"At UC, we know a lot about post-cardiac arrest seizures, so when we got the call and heard what was going on, we made room for her,” says Brandon Foreman, MD, an assistant professor of neurology. "If a patient is in a coma, it can be hard for a standard EEG to determine what is going on inside the brain; that is where the continuous monitoring becomes critical.”

Read more about Mary’s story 

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.